104 related articles for article (PubMed ID: 7044098)
1. Cisplatin in the treatment of metastatic breast carcinoma: A prospective randomized trial of two dosage schedules.
Forastiere AA; Hakes TB; Wittes JT; Wittes RE
Am J Clin Oncol; 1982 Jun; 5(3):243-7. PubMed ID: 7044098
[TBL] [Abstract][Full Text] [Related]
2. A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).
Gradishar WJ; Stephenson P; Glover DJ; Neuberg DS; Moore MR; Windschitl HE; Piel I; Abeloff MD
Cancer; 2001 Nov; 92(10):2517-22. PubMed ID: 11745184
[TBL] [Abstract][Full Text] [Related]
3. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies.
Herman TS; Jochelson MS; Teicher BA; Scott PJ; Hansen J; Clark JR; Pfeffer MR; Gelwan LE; Molnar-Griffin BJ; Fraser SM
Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1273-9. PubMed ID: 2689396
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin and etoposide: an effective treatment for refractory breast carcinoma.
Cox EB; Burton GV; Olsen GA; Vugrin D
Am J Clin Oncol; 1989 Feb; 12(1):53-6. PubMed ID: 2643295
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: a cancer and leukemia group B study.
Miller AA; Hargis JB; Lilenbaum RC; Fields SZ; Rosner GL; Schilsky RL
J Clin Oncol; 1994 Dec; 12(12):2743-50. PubMed ID: 7527456
[TBL] [Abstract][Full Text] [Related]
6. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin in the management of breast cancer.
Sledge GW; Roth BJ
Semin Oncol; 1989 Aug; 16(4 Suppl 6):110-5. PubMed ID: 2669132
[TBL] [Abstract][Full Text] [Related]
8. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin.
Klaassen U; Wilke H; Seeber S
J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.
Tannock IF; Boyd NF; DeBoer G; Erlichman C; Fine S; Larocque G; Mayers C; Perrault D; Sutherland H
J Clin Oncol; 1988 Sep; 6(9):1377-87. PubMed ID: 2458438
[TBL] [Abstract][Full Text] [Related]
10. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
Gralla RJ; Casper ES; Kelsen DP; Braun DW; Dukeman ME; Martini N; Young CW; Golbey RB
Ann Intern Med; 1981 Oct; 95(4):414-20. PubMed ID: 7025719
[TBL] [Abstract][Full Text] [Related]
12. Infusional 5-fluorouracil/leucovorin plus paclitaxel and cisplatin in the first-line treatment of metastatic breast cancer: results of a phase II study.
Klaassen U; Wilke H; Müller C; Borquez D; Harstrick A; Seeber S
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-58-S17-60. PubMed ID: 9374095
[TBL] [Abstract][Full Text] [Related]
13. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma.
Conzen SD; Kaufman PA; Arvizu C; LeMarbre P; Maurer LH; Mott LA; Mills LE
Cancer; 1996 Nov; 78(9):1906-11. PubMed ID: 8909310
[TBL] [Abstract][Full Text] [Related]
15. Infusional 5-FU, folinic acid, paclitaxel, and cisplatin for metastatic breast cancer.
Klaassen U; Wilke H; Müller C; Borquez D; Korn M; Achterrath W; Harstrick A; Diergarten K; Seeber S
Oncology (Williston Park); 1997 Apr; 11(4 Suppl 3):38-40. PubMed ID: 9144690
[TBL] [Abstract][Full Text] [Related]
16. MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Smith IE; Powles TJ
Oncology; 1993 Apr; 50 Suppl 1():9-15. PubMed ID: 8483562
[TBL] [Abstract][Full Text] [Related]
17. Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer.
Tolcher AW; Gelmon KA
Semin Oncol; 1995 Aug; 22(4 Suppl 8):28-32. PubMed ID: 7638639
[TBL] [Abstract][Full Text] [Related]
18. Weekly cisplatin 20 mg/m2 in patients with carcinoma of cervix receiving pelvic radiotherapy at Srinagarind Hospital: a randomized controlled trial.
Punushapai U; Yuenyao P; Chumworathayi B; Luanratanakorn S; Udomthavornsuk B
Asian Pac J Cancer Prev; 2010; 11(1):201-7. PubMed ID: 20593957
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Herson J; Rutledge FN
Obstet Gynecol; 1982 Feb; 59(2):225-8. PubMed ID: 7043339
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Bonomi P; Blessing JA; Stehman FB; DiSaia PJ; Walton L; Major FJ
J Clin Oncol; 1985 Aug; 3(8):1079-85. PubMed ID: 3894589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
